medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2019, Number 2

<< Back Next >>

Arch Inv Mat Inf 2019; 10 (2)

Prenatal risk in hyperthyroidism. Review article and series of case studies

Zavala BB, Espinosa MNC, Viruéz SJA, Pérez CÁA, Álvarez LAI, Malanco HLM, Briones GJC

Language: Spanish
References: 41
Page: 65-73
PDF size: 154.26 Kb.


ABSTRACT

Introduction: Graves disease accounts for 85 to 90% of all cases, during pregnancy poses difficulty for diagnosis by physiological changes, the hypothalamic pituitary thyroid is a different fetal development the maternal axis, so it is important to know your interactions to manage this company risk approach in each of the trimesters of pregnancy. Objective: To provide a comprehensive picture of the effects of this disease on maternal and fetal health implications, provide a management protocol of prenatal care and monitoring to improve prognosis, and present the perinatal outcomes of a series of cases. Material and methods: A literature review and management guidelines was conducted in hyperthyroidism. Moreover 12 records were collected in 2014 hyperthyroidism and pregnancy, and perinatal outcomes were analyzed. Results: The perinatal outcomes in birth rates dropped from 12 patients with 66% newborn with intrauterine growth restriction, prematurity 41.6%, 41.6% preeclampsia developed, in four of these patients was associated with goiter. Conclusions: In our experience we found that the most common complications associated with hyperthyroidism are preeclampsia, prematurity and intrauterine growth restriction, therefore we consider, in addition to the thyroid control focus attention on prenatal care and risk prediction to intervene promptly in these entities.


REFERENCES

  1. Diagnóstico y tratamiento de la enfermedad de Graves en > 18 años. México: Secretaría de Salud, 2011.

  2. Cignini P, Cafa EV, Gioriandino C, Capriglione S, Spata A, Dugo N. Thyroid physiology and common diseases in pregnancy: review of literatura, J Prenat Med, 2012; 6 (4): 64-71.

  3. Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation, Eur J Endocrinol, 2011; 164: 871-876.

  4. Alamdari S, Azizi F, Delshad H, Sarvghadi F, Amouzergar A, Mehran L. Management of hyperthyroidism in pregnancy: comparison of recomendations of American Thyroid Association and Endocrine Society, J Thyroid Res, 2013; 2013: 878467. doi: 10.1155/2013/878467.

  5. Stagnaro-Green A, Abalovich M, Alenxander E, Azizi F, Mestman J, Negro R et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum, Thyroid, 2011; 21: 1081-1125.

  6. Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J, Lejeune B. Regulation of maternal thyroid during pregnancy, J Clin Endocrinol Metab, 1990; 71: 276-287.

  7. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health, Endocr Rev, 2010; 31: 702-755.

  8. Stagnaro-Green A, Abalovich M, Alenxander E, Azizi F, Mestman J, Negro R et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum, Thyroid, 2011; 21: 1081-1125.

  9. Fisher DA, Klein AH. Thyroid development and disorders of thyroid function in the newborn, N Engl J Med, 1981; 304 (2): 702-712.

  10. Bernal J, Pekonen F. Ontogenesis of nuclear 3,5,3’-triiodothyronine receptor in human fetal brain, Endocrinology, 1984; 114 (2): 677-679.

  11. Klein AH, Hobel CJ, Sack J, Fisher DA. Effect of intraamniotic fluid thyroxine injection on fetal serum and amniotic fluid iodothyronine concentrations, J Clib Endocrinol Metab, 1978; 47 (5): 1034-1037.

  12. Perelman AH, Johnson RL, Clemons RD, Finberg HJ, Clewell WH, Trujillo L. Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism, J Clin Endocrinol Metabol, 1990; 71 (3): 618-621.

  13. de Escobar GM, Obregón MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development, Best Pract Res Clin Endocrinol Metab, 2004; 18: 225-248.

  14. MacFaul R. Dorner S. Brett EM, Grant DB. Neurological abnormalities in patients treated for hypothyroidism from early life, Arch Dis Child, 1978; 53: 611-619.

  15. Glorieux J, Dussault JH, Letarte J. Guyda H, Morisette J. Preliminary results on the mental development of hypothyroid infants detected by the Quebec screening program, J Pediatr, 1983; 102: 19-22.

  16. Rovet J, Ehrlich R, Sorbara D. Intellectual outcome in children with fetal hypothyroidism, J Pediatr, 1987; 110 (5): 700-704.

  17. Malone MJ, Rosman NP, Szoke M, Davis D. Myelination of brain in experimental hypothyroidism. An electron microscopic and biochemical study of purified myelin isolates, J Neurol Sci, 1975; 26 (1): 1-11.

  18. Alves C, Eidson M, Engle H, Sheldon J, Cleveland WW. Changes in brain maturation detected by magnetic resonance imaging in congenital hypothyroidism, J Pediatr, 1989; 115: 600-603.

  19. Burrow GN. Hyperthyroidism during pregnancy, N Engl J Med, 1978; 298: 150-153.

  20. Pekonen F, Teramo K, Makinen T, Ikonen E, Osterlund K, Lamberg BA. Prenatal diagnosis and treatment of fetal thyrotoxicosis, Am J Obstet Gynecol, 1984; 150 (7): 893-894.

  21. Peleg D, Cada S, Peleg A, Ben-Ami M. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis, Obstet Gynecol, 2002; 99: 1040-1043.

  22. Glinoer D. Thyroid hyperfunction durin pregnancy, Thyroid, 1998; 8 (9): 859-864.

  23. Mänistö T, Vääräsmäki M, Pouta A, Hartikainen A, Roukonen A, Surcel H et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population based cohort study, J Clin Endocrinol Metab, 2009; 94: 772-779.

  24. De Groot L, Abalovich M, Alexabder EK, Amino N, Barbourt L, Cobin Rh et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 2012; 97 (8): 2543-2565.

  25. Sitar DS, Abu-Bakare A, Gardiner RJ. Propylthiouracil disposition in pregnant and post-partum women, Pharmacology, 1982; 25 (1): 57-60.

  26. Majtaba Q, Burrow GN. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole, Obstet Gynecol, 1975; 46 (3): 282-286.

  27. Mandel SJ, Bernt GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis, Thyroid, 1994; 4 (1): 129-133.

  28. Van Dijke CP, Heydendeal RJ, De Kleine MJ. Methimazole, carbimazole, and congenital skin defects, Ann Intern Med, 1987; 106 (1): 60-61.

  29. Milham S, Elledge W. Maternal methimazole and congenital defects in children, Teratology, 1972; 5 (1): 125.

  30. Sherif IH, Oyan WT, Bosairi S, Carrascal SM. Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand, 1991; 70: 461-463.

  31. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis, Obstet Gynecol, 2010; 116: 402-414.

  32. Taipale P, Hiilesmaa V. Sonographic measurement of uterine cervix at 18-22 weeks’ gestation and the risk of preterm delivery, Obstet Gynecol, 1998; 92: 902-907.

  33. Heath VC, Southall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery, Ultrasound Obstet Gynecol, 1998; 12 (5): 312-317.

  34. Iams JD, Johnson FF, Sonek J, Gebauer C, Samueis P. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance, Am J Obstet Gynecol, 1995; 172: 1097-1103.

  35. Berghella V, Kuhlman K, Weiner S, TexeiraL, Wapner RJ. Cervical funneling: sonographic criteria predictive of preterm delivery, Ultrasound Obstet Gynecol, 1997; 10: 161-166.

  36. Fitzpatrick DL, Russell MA. Diagnosis and management of thyroid disease in pregnancy. Obstet Gynecol Clin North Am, 2010; 37 (2): 173-193.

  37. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 37, August 2002. (Replaces Practice Bulletin Number 32, November 2001). Thyroid disease in pregnancy. Obstet Gynecol, 2002; 100: 387-396.

  38. Azizi F, Bahrainian M, Khamseh ME, Khoshniat M. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole, J Pediatr Endocrinol Metab, 2003; 16 (9): 1239-1243.

  39. Rámiz MM, Gutiérrez MA, de la Guerra AC, Lizarraga ZA, Bóveda RJ, de la Villa FM. Crisis tirotóxica (tormenta tioidea). A propósito de dos observaciones, Gac Med Bilbao, 2010; 107 (2): 64-67.

  40. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism, Obstet Gynecol, 1994; 84 (6): 946-949.

  41. Pillar N, Levy A, Holcberg G, Sheiner E. Pregnancy and perinatal outcome in women with hyperthyroidism, Int J Gynaecol Obstet, 2010; 108 (1): 61-64.




2020     |     www.medigraphic.com